Invivyd (IVVD) Payables (2020 - 2025)
Invivyd posted quarterly Payables of $13.7 million for Q4 2025, up 31.55% year-on-year from $10.4 million in Q4 2024, and down 24.08% on a QoQ basis from $18.1 million in Q3 2025.
Invivyd (IVVD) has 6 years of Payables data on file, last reported at $13.7 million in Q4 2025.
- For the quarter ending Q4 2025, Payables rose 31.55% year-over-year to $13.7 million; the trailing twelve-month figure through Dec 2025 stood at $13.7 million (up 31.55% YoY), and the FY2025 full-year result was $13.7 million, up 31.55% from the prior year.
- Payables for Q4 2025 stood at $13.7 million, down from $18.1 million in the prior quarter.
- Across five years, Payables topped out at $18.7 million in Q1 2022 and bottomed at $1.2 million in Q1 2024.
- The 5-year median for Payables is $10.4 million (2024), against an average of $10.9 million.
- The widest annual swing landed in 2024, when Payables slumped 80.25%; it then jumped 648.2% in 2025.
- A 5-year view of Payables shows it stood at $5.8 million in 2021, then plunged by 73.77% to $1.5 million in 2022, then jumped by 424.26% to $8.0 million in 2023, then surged by 31.37% to $10.4 million in 2024, then jumped by 31.55% to $13.7 million in 2025.
- The last three Payables figures came in at $13.7 million (Q4 2025), $18.1 million (Q3 2025), and $18.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | 13.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.74 Mn |
| Sep 30, 2025 | 18.10 Mn |
| Jun 30, 2025 | 18.05 Mn |
| Mar 31, 2025 | 8.74 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Sep 30, 2024 | 17.71 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 7.95 Mn |
| Sep 30, 2023 | 9.17 Mn |
| Jun 30, 2023 | 4.11 Mn |
| Mar 31, 2023 | 5.91 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 16.77 Mn |
| Jun 30, 2022 | 14.23 Mn |
| Mar 31, 2022 | 18.68 Mn |
| Dec 31, 2021 | 5.78 Mn |
| Sep 30, 2021 | 17.56 Mn |
| Jun 30, 2021 | 10.72 Mn |
| Dec 31, 2020 | 8.15 Mn |